Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Agarwal Shefali Create: Alert

All | News | Filings
Date FiledTypeDescription
06/07/2023 4 Agarwal Shefali (Director) has filed a Form 4 on FATE THERAPEUTICS INC
Txns: Granted 40,000 options to buy @ $5.52, valued at $220.8k
08/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/11/2022 4 Agarwal Shefali (See Remarks) has filed a Form 4 on Epizyme, Inc.
Txns: Paid exercise price by delivering 373,154 shares @ $1.39, valued at $518.7k
Exercised 56,527 options to buy @ $1.39, valued at $78.6k
Exercised 43,473 options to buy @ $1.39, valued at $60.4k
Exercised 400,000 options to buy @ $1.39, valued at $556k
06/22/2022 4 Agarwal Shefali (Director) has filed a Form 4 on Gritstone bio, Inc.
Txns: Granted 19,000 options to buy @ $2.22, valued at $42.2k
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/09/2022 4 Agarwal Shefali (See Remarks) has filed a Form 4 on Epizyme, Inc.
Txns: Sold 1,058 shares @ $1.5, valued at $1.6k
02/04/2022 4 Agarwal Shefali (See Remarks) has filed a Form 4 on Epizyme, Inc.
Txns: Sold 2,639 shares @ $1.37, valued at $3.6k
01/28/2022 4 Agarwal Shefali (See Remarks) has filed a Form 4 on Epizyme, Inc.
Txns: Sold 2,922 shares @ $2.02, valued at $5.9k
12/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/19/2021 4 Agarwal Shefali (Director) has filed a Form 4 on Gritstone bio, Inc.
Txns: Granted 937 options to buy @ $9.86, valued at $9.2k
11/19/2021 4 Agarwal Shefali (Director) has filed a Form 4 on Gritstone bio, Inc.
Txns: Granted 38,000 options to buy @ $9.48, valued at $360.2k
11/19/2021 3 Agarwal Shefali (Director) has filed a Form 3 on Gritstone bio, Inc.
06/04/2021 4 Agarwal Shefali (Director) has filed a Form 4 on FATE THERAPEUTICS INC
Txns: Granted 2,681 shares @ $0
Granted 4,334 options to buy @ $68.94, valued at $298.8k
02/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/27/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/07/2020 4 Agarwal Shefali (Chief Medical Officer) has filed a Form 4 on Epizyme, Inc.
Txns: Sold 2,522 shares @ $13.54, valued at $34.1k
06/30/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2020 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
05/05/2020 4 Agarwal Shefali (Director) has filed a Form 4 on FATE THERAPEUTICS INC
Txns: Granted 16,000 options to buy @ $26.59, valued at $425.4k
03/26/2020 4 Agarwal Shefali (Chief Medical Officer) has filed a Form 4 on Epizyme, Inc.
Txns: Granted 1,575 shares @ $0
Sold 1,243 shares @ $15.28, valued at $19k
02/05/2020 4 Agarwal Shefali (Chief Medical Officer) has filed a Form 4 on Epizyme, Inc.
Txns: Granted 12,856 shares @ $0
Granted 61,834 options to buy @ $21.39, valued at $1.3M
01/27/2020 4 Agarwal Shefali (Chief Medical Officer) has filed a Form 4 on Epizyme, Inc.
Txns: Granted 5,000 shares @ $0
Sold 1,843 shares @ $24.64, valued at $45.4k
Sold 2,630 shares @ $20.44, valued at $53.8k
01/07/2020 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
12/06/2019 4 Agarwal Shefali (Chief Medical Officer) has filed a Form 4 on Epizyme, Inc.
Txns: Granted 22,577 shares @ $0
Granted 34,978 options to buy @ $16.61, valued at $581k
07/17/2019 4 Agarwal Shefali (Director) has filed a Form 4 on FATE THERAPEUTICS INC
Txns: Granted 24,000 options to buy @ $22.14, valued at $531.4k
07/17/2019 3 Agarwal Shefali (Director) has filed a Form 3 on FATE THERAPEUTICS INC
06/17/2019 4 Agarwal Shefali (Chief Medical Officer) has filed a Form 4 on Epizyme, Inc.
Txns: Sold 1,195 shares @ $11.97, valued at $14.3k
06/14/2019 4 Agarwal Shefali (Chief Medical Officer) has filed a Form 4 on Epizyme, Inc.
Txns: Granted 4,000 shares @ $0
01/28/2019 4 Agarwal Shefali (Chief Medical Officer) has filed a Form 4 on Epizyme, Inc.
Txns: Granted 32,894 shares @ $0
Granted 151,620 options to buy @ $9.12, valued at $1.4M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy